Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.
about
Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancer.Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.Current approaches to incorporation of radium-223 in clinical practice.p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer.BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations.Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.Current treatment strategies for advanced prostate cancer.No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer.PARP inhibitors for homologous recombination-deficient prostate cancer.Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration-resistant prostate cancer: A retrospective study.Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.
P2860
Q38756919-3A314C24-ED62-4340-9E54-8116223D2E37Q38813222-7EA4B19C-1A34-40B6-AFC0-19D6F164F747Q47212646-653DBE77-7E0F-4BF3-8AD1-B0ACB3B5CEB1Q47231171-702B1656-8B50-4CA3-880A-F3E366A721A2Q47651456-D2EBEA57-3815-413D-B2BA-0C3B6A4368AAQ48189307-D0E852E5-FC61-45F4-A474-7E7137599CA5Q48561494-4D053484-FD77-422E-9EAA-E14E98FBE7FAQ49593012-A8FB4673-1B61-46ED-8345-9B7CDC517055Q52623144-B6D20571-F34E-4169-BDEE-AD00470BECF7Q53712237-01D0C4D7-8970-404A-A098-B2E299ED3176Q53738928-71260044-A3F5-4D0A-9BF7-CB94F0AEB6EA
P2860
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@en
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@nl
type
label
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@en
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@nl
prefLabel
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@en
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@nl
P2093
P2860
P356
P1433
P1476
Comparing Sequencing of Abirat ...... Cancer: A Retrospective Study.
@en
P2093
Benjamin L Maughan
Brandon Luber
Emmanuel S Antonarakis
Rosa Nadal
P2860
P356
10.1002/PROS.23246
P577
2016-08-16T00:00:00Z